Can therapy help HIV patients with depression and insulin resistance?
Part of Hormones & metabolism, Immune system & allergy, Infections clinical trials.
This study tests if cognitive behavioral therapy (a type of talk therapy) can improve how your body handles sugar (insulin resistance) for people living with HIV who also have depression. You may join if you have HIV, are on stable HIV meds, feel depressed, and do not have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have HIV and have been on the same HIV medications for at least 6 months
- You have moderate to severe depression symptoms (like feeling down or losing interest in things) in the past 2 weeks
- Your blood sugar control (HbA1c) is below 6.5%
- Your HIV viral load is under 75 copies/mL
- You do not have diabetes, bipolar disorder, or a psychotic disorder like schizophrenia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at whether lowering inflammation can help improve depression symptoms in adults living with HIV. You may be able to join if your HIV is well controlled and you are currently experiencing major depression (or a certain type of bipolar depression).
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This study tests whether a remotely taught tai chi and qigong program can improve mood and well-being in people aged 50–75 who are living with HIV. You can join from home using a smartphone.
This study looks at brain activity to understand how depression and cannabis use may be linked in young adults living with HIV. It mainly involves questionnaires, mental health screening, and brain scans, which may help researchers better understand risk factors and brain “underpinnings.”
This study looks at how the HIV medicine dolutegravir works in people who also have major depression. It aims to understand if depression affects how the drug stays in the body, and participants will also take an antidepressant (fluoxetine).
This study tests a mobile health program to help people with HIV manage symptoms of anxiety and depression. It is designed to offer support through your phone and may improve your mood and overall health.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.